By expenditures
| Name | Title | Type |
|---|---|---|
| Carolyn Riddle | Interim Finance Director | Auditee |
| Carolyn Riddle | RIDDLE | Auditee |
| Gaby Miller | Principal | Auditee |
| Rich Larsen | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 369232 | 2024 | 2025-09-30 | Novogradac & Company LLP | $79.61M |
| 358812 | 2023 | 2025-06-13 | Novogradac & Company LLP | $71.01M |
| 35864 | 2022 | 2023-09-27 | Cliftonlarsonallen LLP | $62.46M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 369232 | 2024 | 2025-09-30 | 1156883 | 2024-002 | Material Weakness | Yes | N |
| 369232 | 2024 | 2025-09-30 | 1156882 | 2024-001 | Material Weakness | Yes | N |
| 369232 | 2024 | 2025-09-30 | 1156881 | 2024-002 | Material Weakness | Yes | N |
| 369232 | 2024 | 2025-09-30 | 1156880 | 2024-001 | Material Weakness | Yes | N |
| 358812 | 2023 | 2025-06-13 | 1141176 | 2023-003 | Material Weakness | Yes | N |
| 358812 | 2023 | 2025-06-13 | 1141175 | 2023-002 | Significant Deficiency | - | N |
| 358812 | 2023 | 2025-06-13 | 1141174 | 2023-001 | Material Weakness | Yes | E |
| 358812 | 2023 | 2025-06-13 | 1141173 | 2023-003 | Material Weakness | Yes | N |
| 358812 | 2023 | 2025-06-13 | 1141172 | 2023-002 | Significant Deficiency | - | N |
| 358812 | 2023 | 2025-06-13 | 1141171 | 2023-001 | Material Weakness | Yes | E |
| 358812 | 2023 | 2025-06-13 | 564734 | 2023-003 | Material Weakness | Yes | N |
| 358812 | 2023 | 2025-06-13 | 564733 | 2023-002 | Significant Deficiency | - | N |
| 358812 | 2023 | 2025-06-13 | 564732 | 2023-001 | Material Weakness | Yes | E |
| 358812 | 2023 | 2025-06-13 | 564731 | 2023-003 | Material Weakness | Yes | N |
| 358812 | 2023 | 2025-06-13 | 564730 | 2023-002 | Significant Deficiency | - | N |
| 358812 | 2023 | 2025-06-13 | 564729 | 2023-001 | Material Weakness | Yes | E |
| 35864 | 2022 | 2023-09-27 | 607614 | 2022-004 | Significant Deficiency | Yes | N |
| 35864 | 2022 | 2023-09-27 | 607613 | 2022-003 | Material Weakness | Yes | N |
| 35864 | 2022 | 2023-09-27 | 607612 | 2022-002 | Significant Deficiency | Yes | L |
| 35864 | 2022 | 2023-09-27 | 607611 | 2022-001 | Significant Deficiency | Yes | E |
| 35864 | 2022 | 2023-09-27 | 607610 | 2022-003 | Material Weakness | Yes | N |
| 35864 | 2022 | 2023-09-27 | 607609 | 2022-002 | Significant Deficiency | Yes | L |
| 35864 | 2022 | 2023-09-27 | 607608 | 2022-001 | Significant Deficiency | Yes | E |
| 35864 | 2022 | 2023-09-27 | 607607 | 2022-003 | Material Weakness | Yes | N |
| 35864 | 2022 | 2023-09-27 | 607606 | 2022-002 | Significant Deficiency | Yes | L |
| 35864 | 2022 | 2023-09-27 | 607605 | 2022-001 | Significant Deficiency | Yes | E |
| 35864 | 2022 | 2023-09-27 | 31172 | 2022-004 | Significant Deficiency | Yes | N |
| 35864 | 2022 | 2023-09-27 | 31171 | 2022-003 | Material Weakness | Yes | N |
| 35864 | 2022 | 2023-09-27 | 31170 | 2022-002 | Significant Deficiency | Yes | L |
| 35864 | 2022 | 2023-09-27 | 31169 | 2022-001 | Significant Deficiency | Yes | E |
| 35864 | 2022 | 2023-09-27 | 31168 | 2022-003 | Material Weakness | Yes | N |
| 35864 | 2022 | 2023-09-27 | 31167 | 2022-002 | Significant Deficiency | Yes | L |
| 35864 | 2022 | 2023-09-27 | 31166 | 2022-001 | Significant Deficiency | Yes | E |
| 35864 | 2022 | 2023-09-27 | 31165 | 2022-003 | Material Weakness | Yes | N |
| 35864 | 2022 | 2023-09-27 | 31164 | 2022-002 | Significant Deficiency | Yes | L |
| 35864 | 2022 | 2023-09-27 | 31163 | 2022-001 | Significant Deficiency | Yes | E |